NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-290-2006-2-US-12 METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-103-2 US DIV 13/296,291 8338104 Abandoned PDF
NCI E-125-2011-2-PCT-01 ANTIBODIES FOR TUMOR GANGLIOSIDES PCT PCT COMB PCT/US2011/060759 Expired
NCI E-290-2006-2-US-14 METHOD OF PREDICTING CHEMOTHERAPY EFFECTIVENESS IN COLON ADENOCARCINOMA PATIENTS, USING MIR-21 US DIV 13/296,545 Abandoned
NIDCR E-032-2013-0-US-01 METHODS OF INDUCING CHONDROGENESIS IN MESENCHYMAL STEM CELLS USING SYNTHETIC TRITERPENOIDS US 61/629,298 Abandoned
NCI E-097-2009-0-US-04 ANTI-HUMAN ROR1 ANTIBODIES US National Stage 13/265,582 9316646 Issued PDF
NCI E-290-2006-2-US-08 METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-16b US DIV 13/295,440 8518647 Abandoned PDF
NCI E-290-2006-2-US-11 METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING let-7g US DIV 13/295,280 8349568 Abandoned PDF
NCI E-290-2006-2-US-15 METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-106a US DIV 13/295,692 8338103 Abandoned PDF
NCI E-290-2006-2-US-07 MICRO-RNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF COLON CANCER-RELATED DISEASES US DIV 13/295,209 8338102 Abandoned PDF
NCI E-025-2011-2-PCT-01 Antibodies To Tumor Endothelial Marker 8 PCT PCT COMB PCT/US2011/060583 Expired
NCI E-025-2011-2-EP-02 Antibodies To Tumor Endothelial Marker 8 EP National Stage 11840238.7 Abandoned
NIAID E-241-2011-0-US-01 HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS BASED VACCINES US 61/559,359 Abandoned
NIAID E-357-2001-1-AU-12 Construction of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virusf AU DIV 2011250694 Expired
NCI E-013-2012-0-US-01 GENE EXPRESSION SIGNATURES OF NEOPLASM RESPONSIVENESS TO THERAPY US 61/558,402 Abandoned
NIAID E-061-2012-0-US-01 ASSAY FOR DIABETES-ASSOCIATED AUTOANTIBODIES US 61/558,193 Abandoned
NIAID E-281-2011-0-US-01 Synthetic Catalase/Superoxide Dismutase Mimetics and Methods For Treating Viral Infections US 61/558,137 Abandoned
NHLBI E-248-2011-0-US-01 METHODS FOR DETECTING INFECTIOUS AGENTS AND A NOVEL PARVOVIRUS DETECTED THEREBY US 61/558,363 Abandoned
CC E-173-2011-0-CN-05 SYSTEM AND METHOD FOR PROBABILISTIC ABLATION PLANNING CN National Stage 201180054995.4 Issued
CC E-173-2011-0-EP-03 SYSTEM AND METHOD FOR PROBABILISTIC ABLATION PLANNING EP National Stage 11787946.0 Issued
NCI E-159-2009-1-US-02 LAT ADAPTER MOLECULE FOR ENHANCED T-CELL SIGNALING AND METHOD OF USE US National Stage 13/319,263 8779095 Issued PDF
CC E-173-2011-0-PCT-02 SYSTEM AND METHOD FOR PROBABILISTIC ABLATION PLANNING PCT PCT PCT/IB2011/054952 Expired
NICHD E-155-1999-0-JP-30 STRUCTURAL MODIFICATION OF 19-NORPROGESTERONE I: 17-a-SUBSTITUTED-11-B-SUBSTITUTED-4-ARYL AND 21-SUBSTITUTED 19-NORPREGNADIENEDIONE AS NEW ANTIPROGESTATIONAL AGENTS JP DIV 2011-244014 Abandoned
NIAID E-253-2011-0-US-01 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE US 61/556,660 Abandoned
NIDCR E-140-2011-1-US-01 DIFFERENTIALLY-EXPRESSED GENE PRODUCTS FOR USE IN THE DIAGNOSIS AND TREATMENT OF SJOGREN'S SYNDROME US 61/556,729 Abandoned
NCATS E-234-2012-0-US-01 PAK Inhibitors for the Treatment of CNS Disorders and Cancer US 61/555,902 Abandoned
NCATS E-256-2010-0-PCT-02 Alpha-Glucosidase Binders and Methods of their use PCT PCT PCT/US2011/059141 Expired
NIAID E-074-2011-1-US-01 INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS US 61/554,323 Expired
NIAID E-299-2011-0-US-01 Use Of Peptide-manganous Complexes To Protect Microorganisms And Cells From Radiation Damage During Creation Of Lethally Irradiated Vaccines US 61/554,136 Abandoned
NHGRI E-324-2001-0-US-04 METHODS FOR ANALYZING HIGH DIMENSIONAL DATA FOR CLASSIFYING DIAGNOSING PROGNOSTICATING AND/OR PREDICTING DISEASES AND OTHER BIOLOGICAL STATES US CON 13/285,687 8620592 Abandoned PDF
NCI E-014-2007-0-SG-19 SMOOTHENED POLYPEPTIDES AND METHODS OF USE SG DIV 201108044-7 Abandoned
NIAID E-014-2011-0-PCT-02 RAPID MOLECULAR ASSAYS FOR SPECIFIC DETECTION AND QUANTITATION OF LOA LOA MICROFILAREMIA PCT PCT PCT/US2011/58565 Expired
NIAID E-281-2010-0-PCT-02 DIAGNOSTIC ASSAYS AND METHODS OF USE FOR DETECTION OF FILARIAL INFECTION PCT PCT PCT/US2011/58561 Expired
NIDCR E-118-2009-0-US-03 MODULATION OF THE TGF-B AND P13K/AKT PATHWAYS IN THE DIAGNOSIS AND TREATMENT OF SQUAMOUS CELL CARCINOMA US National Stage 13/318,219 Abandoned
NHLBI E-173-2009-0-US-06 Selective Access To Cryopreserved Samples US National Stage 13/318,122 8790597 Issued PDF
NINDS E-160-2009-2-JP-05 Quinone Derivative 2,3-Dimethoxy-5-Methyl-6-(10-Hydroxydecyl)-1,4-Benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis JP National Stage 2012-507605 Abandoned
NCI E-199-2010-0-US-02 Fluoroquinolone Derivatives or Sulfonamide Moiety-Containing Compounds as Inhibitors Of Tyrosyl-Dnaphosphodiesterase (TDP1) US ORD 13/283,282 8716295 Issued PDF
NCI E-227-2010-0-PCT-02 METHODS OF TREATING CANCER AND OTHER DISEASES PCT PCT PCT/US2011/57820 Abandoned
NCI E-093-1995-1-US-26 CHIMERIC RECEPTOR GENES AND CELLS TRANSFORMED THEREWITH US CON 13/281,560 Expired
NCI E-224-2011-0-US-01 METHOD OF TREATING HCV INFECTION WITH A SMALL MOLECULE CHK2 INHIBITOR US 61/551,742 Abandoned
NHLBI E-064-2014-1-US-01 Prior Enhanced Compressed Sensing (PRINCE-CS) Reconstruction For Dynamic 2D-Radial Cardiac MRI US CIP 13/280,994 8675942 Abandoned PDF
NINDS E-143-2002-1-HK-13 Method For the Treatment of Multiple Sclerosis HK National Stage 11111457.0 Abandoned
NCI E-236-2010-0-PCT-02 ANTI-MAGE-A3 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE PCT PCT PCT/US2011/57272 Abandoned
NCI E-220-2011-0-US-01 HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER US 61/549,862 Abandoned
NCI E-249-2005-0-AU-06 TREATING OR PREVENTING RENAL CANCER USING A DIMETHANE SULFONATE AU DIV 2011239231 Abandoned
NIDCR E-131-1998-0-HK-36 Thymosin B4 Promotes Wound Repair HK EP 11111350.8 Expired
NCI E-265-2011-0-US-01 ANTI-CD22 CHIMERIC ANTIGEN RECEPTORS.. US 61/549,516 Abandoned
NHLBI E-337-2008-0-US-03 Stent For Valve Replacement US National Stage 13/265,315 Abandoned
NCI E-003-2006-0-US-04 Antibodies and Immunotoxins that Target Human Glycoprotein NMB US CON 13/276,012 8445216 Issued PDF
NICHD E-120-2015-0-NZ-09 Method For On-demand Contraception NZ National Stage 595790 Issued
NCI E-212-2011-0-US-01 Monospecific And Bispecific Human Monoclonal Antibodies Targeting Insulin-Like Growth Factor II (IGF-II) US 61/548,164 Abandoned